The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: Significance of Pregnancy Associated Activated Protein C Resistance

1 January 2001

journal article
review article
Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis

Vol. 85 (01) , 30-35
https://doi.org/10.1055/s-0037-1612659

Abstract

Activated protein C (APC) resistance secondary to Factor V Leiden (FVL) is associated with pregnancy failure and pre-eclampsia (PET). In non-pregnant subjects, the degree of resistance to APC relates to venous thrombosis risk. In pregnancy, resistance to APC occurs in the absence of FVL. We investigated, in an unselected prospective longitudinal study of 1671 pregnant, non-FVL subjects, the relationship of the APC sensitivity ratio (APC:SR) with demographic variables and pregnancy outcome. Lower APC:SR values at 7-16 weeks gestation were observed in subjects who subsequently developed PET (median APC:SR 2.55, IQR 2.29-2.70 vs 2.69, IQR 2.48-2.93, Mann-Whitney U-test p = 0.003) in the current pregnancy. An APC:SR < the median (2.69) at 7-16 weeks was associated with a 2.95-fold increased risk (CI₉₅ 1.2-7.4) of PET in the current pregnancy. No relationship between the APC:SR, at any gestation, and fetal loss was observed. An inverse correlation between the APC:SR and birth weight was noted. Higher APC:SRs were observed in blood group O subjects and smokers. An inverse relationship of the APC:SR with age, diastolic blood pressure and total serum cholesterol was observed.

Keywords

This publication has 25 references indexed in Scilit:

Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight
The Lancet, 1999
Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy
Thrombosis and Haemostasis, 1998
Factor V Leiden Is Associated with Repeated and Recurrent Unexplained Fetal Losses
Thrombosis and Haemostasis, 1997
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
British Journal of Haematology, 1997
Increased fetal loss in women with heritable thrombophilia
The Lancet, 1996
A modification of the APC resistance test and its application to the study of patients on coumarin therapy
Thrombosis Research, 1996
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
New England Journal of Medicine, 1995
Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsia
BJOG: An International Journal of Obstetrics and Gynaecology, 1994
Mutation in blood coagulation factor V associated with resistance to activated protein C
Nature, 1994
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
Proceedings of the National Academy of Sciences, 1993